Regulation of DNA Methylation by Cannabidiol and Its Implications for Psychiatry: New Insights from In Vivo and In Silico Models
Cannabidiol (CBD) is a non-psychotomimetic compound present in cannabis sativa. Many recent studies have indicated that CBD has a promising therapeutic profile for stress-related psychiatric disorders, such as anxiety, schizophrenia and depression. Such a diverse profile has been associated with its...
Main Authors: | Luana B. Domingos, Nicole R. Silva, Adriano J. M. Chaves Filho, Amanda J. Sales, Anna Starnawska, Sâmia Joca |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-11-01
|
Series: | Genes |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4425/13/11/2165 |
Similar Items
-
The Cannabis-Induced Epigenetic Regulation of Genes Associated with Major Depressive Disorder
by: Guldar Sayed Mohammad, et al.
Published: (2022-08-01) -
DNA Methylation Targeting: The DNMT/HMT Crosstalk Challenge
by: Omar Castillo-Aguilera, et al.
Published: (2017-01-01) -
Melatonin and cancer suppression: insights into its effects on DNA methylation
by: Amirhossein Davoodvandi, et al.
Published: (2022-09-01) -
DNA Methylation in Regulatory T Cell Differentiation and Function: Challenges and Opportunities
by: Lu Bai, et al.
Published: (2022-09-01) -
Methylation-Based Therapies for Colorectal Cancer
by: Klara Cervena, et al.
Published: (2020-06-01)